sign uplog in
Want to go ad-free? Find out how, here.

PEB - Pacific Edge profile

This is a basic profile of an NZX50 listed company. It is not investment advice. We recommend you contact a qualified adviser if you need more information.

Pacific Edge


NZX code: PEB
Short name: Pacific Edge
Legal name: Pacific Edge Limited
Industry sector: Cancer Research
NZX50 rank: 41 of 50
Head office address: Level 10, Otago House, Cnr Moray Place and Princes Street, Dunedin
Chairman: Chris Gallaher
Chief executive: David Darling
Financial year ended: March
Locations: New Zealand
Auditor: Pwc
Bankers: BNZ, ANZ, Heartland Bank, (Dunedin)

[back to full list]

Financial statement history

A. Recent trading and performance summary:

NPAT Earnings
per share
fye March mln mln cents
2016 $4.98 -$15.5 -4.3
2017 $8.06 -$21.0 -5.5
2018 $3.40 -$19.7 -4.5
2019 $3.82 -$17.9 -3.6
2020 $4.37 -$19.0 -3.2

[back to full list]

B. Recent financial position summary:

fye March mln mln %
2016 $32.3 $2.5 92.3
2017 $23.6 $2.7 88.6
2018 $19.7 $3.0 84.8
2019 $16.6 $2.7 83.7
2020 $19.3 $4.8 75.1

[back to full list]

C. Recent cash flows and positions:

Cash and equiv. 
at year end
fye March mln mln mln
2016 $33.4 $32.3 $4.16
2017 $20.2 $17.8 $6.56
2018 $20.1 $21.4 $5.24
2019 $17.1 $17.5 $4.85
2020 $17.6 $20.6 $1.76

[back to full list]

Description of trading activities 

Pacific Edge is a cancer diagnostics company. They develop and commercialize diagnostic and prognostic tools for early detection and management of Cancers.

[back to full list]

CEO profile

David Darling has 30 years' experience in life sciences and biotech. He became CEO in 2014. He has held a number of positions in governance, executive and senior management joining Pacific Edge from Fletcher Challenge.

Chairman profile

Chris Gallaher joined the board in 2016. He became chairman in August of 2016. He has held position in both CEO and CFO roles with a number of large international companies and was a partner in Arthur Young Chartered accountants. He was previously CFO of Fulton Hogan.


Company website:
Investor information:
NZX listing:
Annual reports:

[back to full list]